[18F]DCFPyL Synthesis via Segmented Radiofluorination and Deprotection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing [18F]DCFPyL are inefficient, resulting in variable yields and low specific activities, which limits its effectiveness in prostate cancer imaging.

Innovation Solution

A method involving radiofluorination of a DCFPyL precursor with ester moiety protecting groups, followed by deprotection with phosphoric acid and purification, is developed. This method can be automated using a radiofluorination module or an ELIXYS automated radiochemistry synthesizer, allowing for higher yields and specific activities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current synthesis methods are used, then the synthesis process is simpler, but the radiochemical yield and specific activity are lower

Engineering Contradiction:
Improveradiochemical yieldVSAvoidsynthesis process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The synthesis process is divided into distinct modular steps: (1) anion exchange to isolate [18F]fluoride, (2) nucleophilic substitution with the precursor, (3) deprotection of ester groups, and (4) purification. Each step is optimized independently, allowing the complex overall process to achieve high radiochemical yield while maintaining manageability through systematic segmentation of the synthesis pathway.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The precursor is pre-synthesized with ester protecting groups attached to the carboxylic acid moieties. This preliminary protection allows the radiofluorination step to proceed without interference from carboxylic acid groups, and enables subsequent selective deprotection to achieve the final product with high purity and specific activity.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If current synthesis methods are used, then the synthesis time is shorter, but the specific activity is lower

Engineering Contradiction:
Improvespecific activityVSAvoidsynthesis time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The synthesis protocol maintains continuous useful action by performing deprotection of the ester groups immediately after radiofluorination, without isolating the intermediate. The reaction mixture proceeds directly through deprotection and then purification, eliminating idle time and ensuring that the radioactive [18F] label is incorporated into the final high-specific-activity product without unnecessary delays.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The method employs specific parameter optimizations including using 0.1 M sodium hydroxide for deprotection at controlled temperature, and adjusting the mobile phase composition during HPLC purification (water/acetonitrile gradients with 0.1% formic acid). These parameter changes maximize both the speed and efficiency of each step, achieving high specific activity within an optimized time frame.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If ester protecting groups are used, then the radiofluorination reaction is more efficient, but the deprotection step adds complexity

Engineering Contradiction:
Improveradiofluorination efficiencyVSAvoidnumber of synthesis steps
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The protocol merges the deprotection step with the purification step by performing base-catalyzed hydrolysis of the ester groups in the same reaction vessel, then directly injecting the mixture into the HPLC system. The C18 reverse-phase column selectively retains the deprotected [18F]DCFPyL while allowing removal of byproducts, effectively combining chemical transformation and purification into a streamlined sequence that minimizes additional complexity.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves higher radiochemical yields and specific activities of [18F]DCFPyL, meeting or exceeding all standard quality control acceptance criteria, thereby enhancing its utility in prostate cancer imaging.

Implementation Method 1

deprotecting the ester moiety protecting groups of the radiofluorinated DCPFPyL precursor of step (i) with phosphoric acid to form [18F]DCFPyL

Methodology Applied
Scientific EffectDeprotection:

Implementation Method 2

deprotecting the ester moiety protecting groups of the radiofluorinated DCPFPyL precursor of step (i) with phosphoric acid

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

purifying the [18F]DCFPyL from the reaction mixture of step (ii) to provide [18F]DCFPyL

Methodology Applied
Scientific EffectPurification: Purification

Data Source

PatentUS20250162993A1Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18f]dcfpyl
Publication Date: 2025.05.22 JOHNS HOPKINS UNIVERSITY
  • US20250162993A1 patent drawing
  • US20250162993A1 patent drawing
  • US20250162993A1 patent drawing

AI summary

Methods, and related compositions. for the improved synthesis of [18F]DCFPyL are disclosed. Also provided are methods, and related compositions. for the use of [18F]DCFPyL so produced.